>
Industry
Biotechnology
Topic
Product Launch
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Product Launch in Biotechnology

... therapies to be initiated BURLINGAME, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc., (OTCQB: HGEN) ("Humanigen"), a biopharmaceutical company focused on the development of ...
... Comprehensive Positive Phase 3 Data for Alexion's ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria Presented at American Society of ...
... routine CAR-T cellular immunotherapy BURLINGAME, Calif., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc., (OTCQB: HGEN) ("Humanigen"), a biopharmaceutical company focused on the development of ...
... WIRE --PotNetwork Holdings, Inc. (OTC Pink: POTN) announced today that its subsidiary, Diamond CBD, launched on Black Friday its consumer retail program for shopping malls ...
... 2.4.10 Pacific Biosciences 2.4.9 Genomic Health 2.4.8 Oxford Nanopore Technologies 2.4.7 BGI Genomics Co. Ltd. 2.4.6 GE Global Research 2.4.5 Qiagen 2.4.4 Complete Genomics - ...
... Syndrome by Year-End -- BOSTON, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of ...
... of America 5. Country Market Sizes - North America 4.41 Illumina and BGI Compete in Sequencing Instrumentation 4.40 $2M Whole-Genome Sequencing Pilot for Sick Newborns ...
... in calendar 2020 SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo"), a biotechnology company pioneering the development of 3D bioprinted ...
... neoantigen identification CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today highlighted data ...
... Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the previously announced acquisition of Syntimmune has ...
Subscribe now for full coverage on Product Launch in Biotechnology
Start My Free Trial